Myres Larry

Avg. Two Year Performance

No purchase track record

32% Avg. Sale Return

15% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	3%	7%	28%	40%	32%
Sale Success Rate	4 of 7	4 of 7	6 of 7	7 of 7	5 of 6

Sequenom Inc.

Drugs » Biotechnology

VP, Operations:

Holdings: 5.0K shares

Sentiment

Avg. Two Year Performance

No purchase track record

32% Sale Return 15% Compound

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--